Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 47 results found. Search for [ ranbaxy lab ]

Results 1 to 21 of 47
PB Jayakumar
New Delhi, July 22, 2019
Zydus Cadila, India's fourth-largest drug company by revenue, is banking big on research of new drugs, even though others have bowed out. Zydus expects the new drug business to grow to Rs 3,500 crore in four-five years


P.B. Jayakumar
New Delhi, April 30, 2018
Drug companies are moving up the value chain, transforming into complex generic manufacturers with high end R&D facilities.


PB Jayakumar
New Delhi, June 16, 2017
The US drug regulator Food and Drug Administration (FDA) has banned all drug imports from the Mumbai based mid-cap drug company Ipca Laboratories due to non-compliance in manufacturing standards.


Rajeev Dubey
Delhi, May 1, 2017
A group of inheritors takes charge with new ideas and new strategies


By P.B. Jayakumar
Delhi, July 27, 2016
But nothing sticks in public memory more than his most recent avatar - Ajay Piramal, the investor. The contrarian, who is placing big bets on businesses ranging from financial services to healthcare on one hand, and drug discovery and realty on the other.


PTI
New Delhi, June 10, 2016
Currently, FDI up to 100 per cent is permitted in new projects in the pharmaceutical sector, but in brownfield ones-the existing companies-the foreign investment is permitted through FIPB approval.


By Dinesh S. Thakur
Delhi, February 25, 2016
To realise its true potential and gain rapid in-market acceptance Indian pharma must have capable leaders with unimpeachable record to head its regulatory body.


BT Online
New Delhi, December 15, 2015
Shares of Sun Pharma gained nearly 2 per cent after the drug major said it has sold its manufacturing unit in Ohio to Nostrum Laboratories Inc.


PTI
New Delhi, December 14, 2015
Sun Pharmaceutical Industries said in a regulatory filing that one of its wholly owned subsidiaries has entered into an agreement with Nostrum Laboratories Inc for the divestment of the Bryan (Ohio) unit in the US.


BT Online Bureau
New Delhi, June 30, 2015
The share price of Nestle India rallied 4.6 per cent in the day's trading session after the High Court allowed it to export is India-banned product Maggi.


E Kumar Sharma
New Delhi, January 24, 2015
US health-care giant Abbott has high stakes in localising its Indian arm. The challenge for rivals in branded generics is real.


PTI
New Delhi, November 26, 2014
Ranbaxy Laboratories had sued US Food and Drug Administration (USFDA) over revoking an approval to sell generic versions of Nexium and Valcyte in the US market.


Zeba Siddiqui
Mumbai, November 18, 2014
The FDA told Ranbaxy that its decision to grant approvals for both the drugs were \"in error\", after it found that Ranbaxy's plants did not meet its quality standards.


Zeba Siddiqui
Mumbai, November 12, 2014
Leading generic drugmakers Dr Reddy's Labs and Glenmark Pharma in November posted a drop in their second-quarter US sales, blaming the slowdown in the approval process.


E Kumar Sharma
November 7, 2014
The FDA has also denied Ranbaxy 180-day marketing exclusivity for a generic version of Roche's antiviral drug Valcyte, according to a company statement on Thursday.


Zeba Siddiqui
Mumbai, November 7, 2014
The move comes after Ranbaxy Labs said on Thursday that FDA had stripped the company of its tentative approval to launch the first copy of the drug due to quality control issues at its plants.


PTI
Mumbai, October 28, 2014
Continued fall in global crude oil prices, which will help India cut current account deficit and ease fuel price inflation further, also buoyed sentiments, brokers said.


PTI
Mumbai, August 20, 2014
The Sensex ended down 106.38 points, or 0.40 per cent, to end at 26,314.29 after surging to 26,504.52 intra- day. Losses in counters like ONGC, GAIL, RIL, SBI, Axis Bank, Maruti Suzuki, ITC and L&T mainly weighed on the market sentiment.


PTI
Mumbai, July 3, 2014
A total of 447 stocks touched their 52-week highs on the BSE, including Lupin, Ranbaxy Lab, Strides Arcolab, Sun Pharma, Tata Motors, Tech Mahindra and TVS Motor.


E. Kumar Sharma
July 2, 2014
Given the optimistic mood in the country about the reform process, Satish Reddy, President of the Indian Pharmaceutical Alliance (IPA) and Chairman at Dr Reddy's Labs, said that \"the industry will be looking for signals of revival of the growth story\".


PAGES 1 OF 3  123